The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good news.
Https://www.londonstockexchange.com/news-article/OCTP/final-dose-administered/16137098
Only 5 to wake up to disappointment then haha
Only 6 trading days left in Q3.
212 showing 14.8 Hahaha
Goggle slowing 11% up, something up.
This last week was an obvious opportunity to buy, MM's know news is imminent and agreed now news is good news, roll on phase two with ever increasing JV on the cards. M/C is ridiculously low
No news is good news...trial would have been pulled if safety concerns by now...all good i reckon
Am hopeful when you can dummy sell your holding but can't buy back the same amount things maybe looking up.
Plenty of articles on various platforms today , link below , it’s going to get exciting soon
https://www.linkedin.com/posts/oxford-cannabinoid-technologies_octp-activity-7109853818086912000-PJb0?utm_source=share&utm_medium=member_ios
Hopefully see some Hemo profit put here - timing could be good. Not long left of this quarter….
What we really need is a cracking RNS like HEMO here.
Not Capital re-organisation.
Go back to the drawing board bod.📝
I just hope we get an update before AMG.
Otherwise AMG will be more repeats 🤬and no real news
Before the AGM hopefully
598k sells and over 3 million buys.
Must be getting closer to news.
Alot of buys today
You have to be a real moron to care about market cap in a company where the share price is below 1p. The company is cheap, load up and see if it 10 bags or 100 bags in time.
Yes it's just a wheeze to allow them more flex. It only effect nominal value, no effect whatsoever on the shares worth. Hoping they need this additional flex in order to take product to market :)
Windsor conveniently only arrived here yesterday Nigel50.....go figure
Octp, to add, this is stated in supporting notes, have NO plans to increase the number of shares apart from the normal employee share options.
The post from Windsor, laughable. Utter nonsense.
Ahhh. Understood. That makes sense. Thanks.
Does this help. This is the way i see it...
It's a purely a procedural process allowing the Company to reduce the nominal value of its shares from 1p to 0.1p WITHOUT diluting existing shareholders as the Companies Act prohibits companies from issuing shares at below the nominal value.
It'll have ZERO impact on shareholders - no new ordinary shares are being issued.
The reason for it is to allow the company to take advantage of the general authority to issue new shares (up to 20% of share capital only) it's requesting at the AGM - that means the Company is able to be more agile as and when it wants to raise some cash.
This is all subject to a shareholder vote at the AGM so is entirely in shareholder control.
There's no impact on existing warrants currently issued by the company, which have a 5p/share exercise price.
There's nothing fishy going on!
Amy more thoughts or questions please send to me and i can try and pass on to the BOD if thats helps?
david burton.tms@gmail.com
You can gloss it up all you like, but your virtually having a 90% haircut .
I've just read the entire prospectus the strange part is if the SP is above 1p than they can do a offering which as I believe correctly they have enough money to march and with results on the first phase soon to be published, why don't they at least give it to march to see if the SP goes above a penny before they do this reorganisation route.
I believe they may have approach various investments groups but been unsuccessful in raising funds.
They are now asking shareholders to lose 90% of their remaining investment.
The deferred shares are deemed worthless and although they mention .9p a share they effectively are being used as cash on hand and the deferred shares will be used as Remaining shares in the future to raise additional funds.
Bottom line is they are taking 90% of the market cap
I'm grateful for the explanation, but still have questions. Some of the resolutions being voted on suggest (to my untrained eye) to grant the directors more power over the deferred shares than I would be comfortable with.
I'm very happy there's knowledgeable people here who don't mind sharing their expertise - thank you :)